Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
290
NCT07164183
Clinical Study to Compare Efficacy and Safety of Indinol Forto® 200 mg Capsules and Visanne 2 mg Tablets in Treatment of Endometriosis
Phase: Phase 3
Role: Lead Sponsor
Start: Sep 11, 2025
Completion: Nov 30, 2026